Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,199Revenue (TTM) $M6.3Net Margin (%)-3,470.5Altman Z-Score5.3
Enterprise Value $M5,035EPS (TTM) $-2.5Operating Margin %-3,502.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-5.3Pre-tax Margin (%)-3,470.5Higher ROA y-yN
Price/Book15.110-y EBITDA Growth Rate %--Quick Ratio19.4Cash flow > EarningsY
Price/Sales8185-y EBITDA Growth Rate %--Current Ratio19.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-49.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-67.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M88.2ROIC % (ttm)-577.1Gross Margin Increase y-yN

Gurus Latest Trades with NBIX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

NBIX is held by these investors:

NBIX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lippoldt DarinChief Legal Officer 2017-09-06Sell100$60-1.78view
Gano KyleChief Business Development Off 2017-09-06Sell4,607$60-1.78view
Bozigian Haig P.Chief Development Officer 2017-09-06Sell26,250$60-1.78view
OBrien Christopher FlintChief Medical Officer 2017-09-05Sell52,817$57.52.49view
Lippoldt DarinChief Legal Officer 2017-08-09Sell5,000$557.15view
Grigoriadis Dimitri E.Chief Research Officer 2017-08-09Sell15,354$557.15view
Bozigian Haig P.Chief Development Officer 2017-08-04Sell22,500$5017.86view
OBrien Christopher FlintChief Medical Officer 2017-07-27Sell8,734$5017.86view
Grigoriadis Dimitri E.Chief Research Officer 2017-05-23Sell10,000$53.3910.38view
Lloyd-Smith MalcolmChief Regulatory Officer 2017-05-19Sell9,960$53.639.88view

Quarterly/Annual Reports about NBIX:

News about NBIX:

Articles On GuruFocus.com
Neurocrine Announces Data on the Real-World Patient Impact of TD from the RE-KINECT Study to be Pres Sep 15 2017 
Neurocrine Biosciences to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Sep 06 2017 
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Sep 06 2017 
5 Health Care Companies Gurus Are Buying Sep 05 2017 
Neurocrine Biosciences to Present at the Baird 2017 Global Healthcare Conference Aug 30 2017 
Neurocrine Biosciences Reports Second Quarter 2017 Results Aug 03 2017 
Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2017 Results Jul 28 2017 
Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer Jul 21 2017 
Neurocrine Biosciences to Present at the Goldman Sachs 38th Annual Global Healthcare Conference Jun 09 2017 
Neurocrine Announces Presentations Related to INGREZZA® (valbenazine) Capsules at the 21st Internat Jun 02 2017 

More From Other Websites
No related articles found.

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat